CompanyNasdaqSan Diego, CA
Aethlon Medical INC
Aethlon Medical develops the Hemopurifier, a clinical-stage immunotherapeutic device that depletes cancer-promoting exosomes and life-threatening viruses from circulation, and is intended for use in organ transplantation.
8-KSep 17Latest SEC filing, period to Sep 17
Form DDec 23$2.2M sold